Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report
- PMID: 34785566
- PMCID: PMC10359776
- DOI: 10.1136/ejhpharm-2021-002901
Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report
Abstract
Once administered, risperidone is converted into its pharmacologically active form, paliperidone. Thus, their pharmacological effects are expected to be equivalent. We encountered a psychosis induced by the switch from risperidone to paliperidone.This is the case of a schizoaffective patient stabilised on risperidone long-acting injection (LAI) who consented to switch to paliperidone LAI. On day 0, he received his first dose of paliperidone. On day 86, he presented to the emergency department with an acute psychotic episode. On day 92, he committed a violent act. The patient was restarted on risperidone LAI and stabilised.Risperidone is extensively metabolised to paliperidone via CYP450 2D6. Interindividual and ethnic genetic polymorphism cause variability in CYP450 2D6 phenotypes. In this possible case of low-functioning alleles, the patient had a higher risperidone to paliperidone ratio at steady state. Although risperidone is paliperidone's prodrug, this case highlights the interindividual pharmacotherapeutic response to these two antipsychotics.
Keywords: case reports; drug substitution; mental health; psychiatry; safety.
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: During the previous 36 months, VDB has received fees for consulting from HLS Therapeutics and Otsuka for unrelated work, and speaker fees from HLS Therapeutics and Ostuka for unrelated work.
Figures
Similar articles
-
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.Turk Psikiyatri Derg. 2022 Summer;33(2):146-148. doi: 10.5080/u26315. Turk Psikiyatri Derg. 2022. PMID: 35730516 English, Turkish.
-
A new paliperidone palmitate formulation: how is it different and where does it fit in our array of choices for long-acting formulations of risperidone and paliperidone?Curr Med Res Opin. 2025 Apr;41(4):663-666. doi: 10.1080/03007995.2025.2482654. Epub 2025 Apr 12. Curr Med Res Opin. 2025. PMID: 40126382
-
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.Pharmacoeconomics. 2016 Apr;34(4):363-91. doi: 10.1007/s40273-015-0348-x. Pharmacoeconomics. 2016. PMID: 26883132 Free PMC article.
-
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.Psychiatr Pol. 2017 Feb 26;51(1):7-21. doi: 10.12740/PP/64581. Epub 2017 Feb 26. Psychiatr Pol. 2017. PMID: 28455891 Review. English, Polish.
-
Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.Expert Opin Drug Saf. 2017 Mar;16(3):365-379. doi: 10.1080/14740338.2017.1288716. Epub 2017 Feb 9. Expert Opin Drug Saf. 2017. PMID: 28140680 Review.
References
-
- Stahl SM. Paliperidone. In: Essential psychopharmacology. 6th edn. Cambridge University Press, 2008.
-
- Janssen Pharmaceuticals . Transitioning from other antipsychotics before transitioning to INVEGA SUSTENNA® , 2019. Available: https://www.invegasustennahcp.com/dosing/transitioning [Accessed 26 Jan 2020].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical